ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

CTAG Cloudtag

2.875
0.00 (0.00%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Cloudtag LSE:CTAG London Ordinary Share KYG2215A1076 ORD 0.1P (DI)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 2.875 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Cloudtag Share Discussion Threads

Showing 8251 to 8273 of 9325 messages
Chat Pages: Latest  337  336  335  334  333  332  331  330  329  328  327  326  Older
DateSubjectAuthorDiscuss
11/8/2017
13:39
Good afternoon all.

Tom

avatar333
09/8/2017
07:46
Good morning all.


Andy.

saul goodman
08/8/2017
23:38
Bahv Dattani, Head of Sales for Cloudtag since September 2016Previously Head of Sales UK for JawboneIn fairness, he has had nothing to sell at Cloudtag and needs to make a crust somehow.I'm looking forward to reading the Aberdeen Uni research.
nod
08/8/2017
13:32
Shareholder update regarding recent pre-clinical study.

8th August 2017

CloudTag (CTAG:LN), the company that brings personal monitoring to the wellbeing, fitness and digital health markets, is pleased to share some initial insights and findings from its recent pre-clinical study. The Onitor pilot pre-clinical study which was led from the University of Aberdeen has been completed and is being written up, including quantitative and qualitative outcomes, including theories of behavioural change. The draft report has now been submitted for publication as a mixed methods digital health study by the researchers and authors, Kelly Buchan and Heather Morgan. This will undergo the requisite process of scientific peer review prior to being made publicly available.

Amit Ben-Haim, CEO, said “As part of our ongoing strategy to focus on the clinical benefit of our products, we are enthused by the early results of this study, which bode very positively for the development of our proprietary hardware and software

Cloudtag Inc. Amit Ben-Haim +1 345 949 45 44 contact@cloudtag.com

UK Investor Relations. +44 (0) 20 7052 8469 investors@cloudtag.com

bbmsionlypostafter
08/8/2017
13:23
Good afternoon all.


Andy

saul goodman
03/8/2017
09:55
Good morning all.


Andy

saul goodman
03/8/2017
09:54
Good morning all.

Tom

avatar333
02/8/2017
08:58
Good morning all.


Andy

saul goodman
02/8/2017
08:51
Good morning all. Stretch
stretch armstrong
02/8/2017
08:43
Good morning all.

Tom

avatar333
01/8/2017
09:42
#201

Duly noted with thanks.


Andy

saul goodman
01/8/2017
09:42
Good morning all.


Andy.

saul goodman
01/8/2017
09:29
Nope, not much at all.

A further observation: The beginning of August ends around the middle of August.

Stretch

stretch armstrong
31/7/2017
14:48
There is not much gets past you, Stretch.


Andy

saul goodman
31/7/2017
14:41
Good afternoon all. Not long until the beginning of August I see. Stretch
stretch armstrong
31/7/2017
11:25
Good morning all.


Andy

saul goodman
28/7/2017
09:02
Good morning all.


Andy

saul goodman
28/7/2017
08:48
Good morning all.

Tom

avatar333
27/7/2017
09:57
Good morning all.


Andy

saul goodman
27/7/2017
09:50
Good morning all.

Tom

avatar333
26/7/2017
08:37
Good morning all.

Tom

avatar333
26/7/2017
08:36
Good morning all.


Andy

saul goodman
25/7/2017
15:29
Good afternoon, Olivia.


Andy

saul goodman
Chat Pages: Latest  337  336  335  334  333  332  331  330  329  328  327  326  Older

Your Recent History

Delayed Upgrade Clock